title: [Immunoblastic lymphoma following hairy cell leukemia treated with interferon alpha-2a].
authors.forename: H
authors.initials: H
authors.lastname: Granier
authors.forename: D
authors.initials: D
authors.lastname: Carre
authors.forename: C
authors.initials: C
authors.lastname: Morand
authors.forename: M
authors.initials: M
authors.lastname: Richecoeur
authors.forename: P
authors.initials: P
authors.lastname: Combes
authors.forename: J
authors.initials: J
authors.lastname: Martin
authors.forename: J
authors.initials: J
authors.lastname: Abgrall
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D007943:Leukemia, Hairy Cell / Q000628:therapy*; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000209:etiology*; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins